Clinical Trial Update: Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating pharmacokinetics and safety of MDR-001 in mild and moderate hepatic impairment; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Liver Failure

Drugs mentioned

• MDR-001

Snippet

Sponsor: MindRank AI Ltd | Conditions: Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), Hepatic Insufficiency (MeSH ID: D048550) | Phase 1 | Status: NOT_YET_RECRUITING